Marle Kraft

Marle Kraft

Auto-generated profile, based on publicly available information

Marle Kraft

Uppsala University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MPMilena Petkova
Milena Petkova
MKMarle Kraft
Marle Kraft
SSSimon Stritt
Simon Stritt
IMInes Martinez-Corral
Ines Martinez-Corral
HOHenrik Ortsäter
Henrik Ortsäter
TMTaija Mäkinen
Taija Mäkinen
Oncogenic mutations in PIK3CA, encoding p110α-PI3K, are a common cause of venous and lymphatic malformations. Vessel type–specific disease pathogenesis is poorly understood, hampering development of efficient therapies. Here, we reveal a new immune-interacting subtype of Ptx3-positive dermal lymphatic capillary endothelial cells (iLECs) that recruit pro-lymphangiogenic macrophages to promote progressive lymphatic overgrowth. Mouse model of Pik3caH1047R-driven vascular malformations showed that proliferation was induced in both venous and lymphatic ECs but sustained selectively in LECs of advanced lesions. Single-cell transcriptomics identified the iLEC population, residing at lymphatic capillary terminals of normal vasculature, that was expanded in Pik3caH1047R mice. Expression of pro-inflammatory genes, including monocyte/macrophage chemokine Ccl2, in Pik3caH1047R-iLECs was associated with recruitment of VEGF-C–producing macrophages. Macrophage depletion, CCL2 blockade, or anti-inflammatory COX-2 inhibition limited Pik3caH1047R-driven lymphangiogenesis. Thus, targeting the paracrine crosstalk involving iLECs and macrophages provides a new therapeutic opportunity for lymphatic malformations. Identification of iLECs further indicates that peripheral lymphatic vessels not only respond to but also actively orchestrate inflammatory processes.

23 May 2025 in Nature Cardiovascular Research
Verified
Journal Article
Open access
PDF file
MKMarle Kraft
Marle Kraft
HSHans Schoofs
Hans Schoofs
MPMilena Petkova
Milena Petkova
JAJorge Andrade
Jorge Andrade
AGAna Rita Grosso
Ana Rita Grosso
TMTaija Mäkinen
Taija Mäkinen
Venous malformations (VMs) are vascular anomalies lacking curative treatments, often caused by somatic PIK3CA mutations that hyperactivate the PI3Kα–AKT–mTOR signaling pathway. Here, we identify a venous-specific signaling circuit driving disease progression, where excessive PI3Kα activity amplifies upstream TIE2 receptor signaling through autocrine and paracrine mechanisms. In Pik3ca H1047R -driven VM mouse models, single-cell transcriptomics and lineage tracking revealed clonal expansion of mutant endothelial cells with a post-capillary venous phenotype, characterized by suppression of the AKT-inhibited FOXO1 and its target genes, including the TIE2 antagonist ANGPT2. An imbalance in TIE2 ligands, likely exacerbated by aberrant recruitment of smooth muscle cells producing the agonist ANGPT1, increased TIE2 activity in both mouse and human VMs. While mTOR blockade had limited effects on advanced VMs in mice, inhibiting TIE2 or ANGPT effectively suppressed their growth. These findings uncover a PI3K–FOXO1–ANGPT–TIE2 circuit as a core driver of PIK3CA-related VMs and highlight TIE2 as a promising therapeutic target.

5 December 2023 in Vascular Biology
Verified
Journal Article
Open access
PDF file
SSSarah Schnabellehner
Sarah Schnabellehner
MKMarle Kraft
Marle Kraft
HSHans Schoofs
Hans Schoofs
HOHenrik Ortsäter
Henrik Ortsäter
TMTaija Mäkinen
Taija Mäkinen
Endothelial cells (ECs) of blood and lymphatic vessels have distinct identity markers that define their specialized functions. Recently, hybrid vasculatures with both blood and lymphatic vessel-specific features have been discovered in multiple tissues. Here, we identify the penile cavernous sinusoidal vessels (pc-Ss) as a new hybrid vascular bed expressing key lymphatic EC identity genes Prox1, Vegfr3,and Lyve1. Using single-cell transcriptome data of human corpus cavernosum tissue, we found heterogeneity within pc-S endothelia and observed distinct transcriptional alterations related to inflammatory processes in hybrid ECs in erectile dysfunction associated with diabetes. Molecular, ultrastructural, and functional studies further established hybrid identity of pc-Ss in mouse, and revealed their morphological adaptations and ability to perform lymphatic-like function in draining high-molecular-weight tracers. Interestingly, we found that inhibition of the key lymphangiogenic growth factor VEGF-C did not block the development of pc-Ss in mice, distinguishing them from other lymphatic and hybrid vessels analyzed so far. Our findings provide a detailed molecular characterization of hybrid pc-Ss and pave the way for the identification of molecular targets for therapies in conditions of dysregulated penile vasculature, including erectile dysfunction.

12 March 2026 in Research Square
Verified
Preprint
Open access
PDF file
MGMarleen Gloger
Marleen Gloger
MKMarle Kraft
Marle Kraft
DPDi Peng
Di Peng
CCClaudia Carlantoni
Claudia Carlantoni
RSRenae Skoczylas
Renae Skoczylas
KKKatarzyna Koltowska
Katarzyna Koltowska
Cell proliferation is central to the proper formation of functional and healthy organs. Although cells divide in all tissues during embryogenesis, how the spatio-temporal control of lymphatic endothelial cell (LEC) number expansion is achieved, remains to be determined. Our comprehensive whole organism time-course analysis has uncovered that spatially restricted LEC proliferation bursts contribute to the morphogenesis of distinct lymphatic vascular beds in zebrafish during embryonic and larval development. Mechanistically, Vegfc-Vegfr3 signalling is necessary and sufficient for LEC proliferation and regulates cell cycle length. Using single-cell transcriptomics, we discover a cohort of genes that generate the unique LEC proliferation code, which is lineage-enriched during the cell proliferation bursts. We confirmed that FKBP1A and LBR are required for endothelial cell proliferation in human primary cell lines. Similarly, the conservation of the lineage-enriched cell proliferation code is present in mouse endothelial cells, whereas in Pik3ca-driven endothelial cell pathologies the cell proliferation code loses its cell type specificity. Thus, our data uncover promising new candidates behind the mechanisms regulating lineage cell number expansion, which could be relevant to future strategies for modulating lymphatic cell proliferation in homeostasis or disease.